CRISPR off targets

CRISPR update: lots of new pubs, news, & maybe a patent finale

Figure-1a-from-Akcakaya-et-al.-paper-Nature-2018

Sometimes it seems like a bunch of stuff in one area, like with CRISPR this week, happens all of a sudden in science. A bunch of fairly high-profile gene editing pubs came out. They generated a lot of news reports. Other news in this arena popped up too, all within a few days. In vivo …

CRISPR update: lots of new pubs, news, & maybe a patent finale Read More »

Analysis: human immunity to Cas9 bigger #CRISPR therapeutic hurdle than off-targets?

Cas9-immunity-pre-print

Some in CRISPR-Cas9-land who are focused on potential future clinical applications are kind of rejoicing or at least sighing a breath of relief. This upbeat swing in the atmosphere (from investors especially) was sparked by retraction of that paper, the one initially reporting tons of supposed off-target CRISPR-Cas9 activity in mice, which turned out to be a “nothing …

Analysis: human immunity to Cas9 bigger #CRISPR therapeutic hurdle than off-targets? Read More »

4 key reasons Mitalipov paper doesn’t herald safe CRISPR human genetic modification

CRISPR-dart-board

We can be confident that human genetic modification via CRISPR’ing of embryos soon will be safe and effective after that new exciting Mitalipov team paper, right? Wrong. The reality is far more complicated and interesting on the tech side. In a nutshell, I see the paper as a significant scientific, but not necessarily medical advance. …

4 key reasons Mitalipov paper doesn’t herald safe CRISPR human genetic modification Read More »